rimonabant

(redirected from Rimonobant)

rimonabant

A selective cannabinoid-1 receptor blocker that has been shown to reduce body weight and the risk of cardiovascular disease in obese people. The drug has been shown capable of achieving substantial weight loss and reducing cardiovascular risk factors. It has aroused excitement among drug manufacturers who hope it may prove effective in the control of smoking as well as excessive calorie and alcohol intake.
References in periodicals archive ?
3,6,48) There are even products claiming to possess E-Cialis (tadalafil) and rimonobant for erectile dysfunction and dieting, respectively, without ever assessing the validity or safety of such claims.
Metformin maintains the weight loss and metabolic benefits following rimonobant treatment in obese women with polycystic ovary syndrome (PCOS).